B. Newstat

1.5k total citations
14 papers, 516 citations indexed

About

B. Newstat is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, B. Newstat has authored 14 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 3 papers in Genetics. Recurrent topics in B. Newstat's work include HER2/EGFR in Cancer Research (9 papers), Cancer Treatment and Pharmacology (9 papers) and Lung Cancer Treatments and Mutations (6 papers). B. Newstat is often cited by papers focused on HER2/EGFR in Cancer Research (9 papers), Cancer Treatment and Pharmacology (9 papers) and Lung Cancer Treatments and Mutations (6 papers). B. Newstat collaborates with scholars based in United Kingdom, United States and Netherlands. B. Newstat's co-authors include Cristina Oliva, David Cameron, Charles E. Geyer, Michelle Casey, Michelle DeSilvio, María Koehler, John Crown, Vicharn Lorvidhaya, Stephen Chan and Wichit Arpornwirat and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and European Journal of Cancer.

In The Last Decade

B. Newstat

13 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Newstat United Kingdom 7 460 175 137 88 74 14 516
Ekaterina Trishkina Russia 7 426 0.9× 335 1.9× 98 0.7× 29 0.3× 196 2.6× 11 563
Lini Pandite United States 8 385 0.8× 318 1.8× 66 0.5× 48 0.5× 118 1.6× 9 565
Eleonora Restuccia Switzerland 15 524 1.1× 212 1.2× 207 1.5× 29 0.3× 154 2.1× 48 626
M. Versola United States 13 368 0.8× 173 1.0× 65 0.5× 88 1.0× 26 0.4× 22 456
S. Stein United States 10 306 0.7× 102 0.6× 113 0.8× 59 0.7× 73 1.0× 15 448
Karen Afenjar United States 6 461 1.0× 218 1.2× 168 1.2× 26 0.3× 193 2.6× 15 571
Rubi K. Li Philippines 8 575 1.3× 112 0.6× 110 0.8× 14 0.2× 192 2.6× 9 666
Alan J. Koletsky United States 9 279 0.6× 238 1.4× 65 0.5× 18 0.2× 71 1.0× 18 444
Donggeng Liu China 7 248 0.5× 145 0.8× 82 0.6× 44 0.5× 70 0.9× 15 343
Tanja Badovinac Črnjević Switzerland 9 238 0.5× 106 0.6× 119 0.9× 16 0.2× 64 0.9× 16 326

Countries citing papers authored by B. Newstat

Since Specialization
Citations

This map shows the geographic impact of B. Newstat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Newstat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Newstat more than expected).

Fields of papers citing papers by B. Newstat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Newstat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Newstat. The network helps show where B. Newstat may publish in the future.

Co-authorship network of co-authors of B. Newstat

This figure shows the co-authorship network connecting the top 25 collaborators of B. Newstat. A scholar is included among the top collaborators of B. Newstat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Newstat. B. Newstat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Guan, Zhongzhen, Binghe Xu, Michelle DeSilvio, et al.. (2013). Randomized Trial of Lapatinib Versus Placebo Added to Paclitaxel in the Treatment of Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Breast Cancer. Journal of Clinical Oncology. 31(16). 1947–1953. 115 indexed citations
2.
Jiang, Ze-Fei, Daniel T. T. Chua, Zhi-Min Shao, et al.. (2011). Lapatinib plus capecitabine in treating HER2-positive advanced breast cancer: efficacy, safety, and biomarker results from Chinese patients. Chinese Journal of Cancer. 30(5). 327–335. 36 indexed citations
3.
4.
5.
6.
Spraggs, Colin F., Linda P. Briley, Nan Bing, et al.. (2009). Hyperbilirubinemia in Lapatinib Treated Patients Is Associated with Gilbert's Syndrome UGT1A1 Polymorphism.. Cancer Research. 69(24_Supplement). 1112–1112. 5 indexed citations
7.
Crown, John, Michelle Casey, David Cameron, B. Newstat, & Steven H. Stein. (2009). 5082 Lapatinib (L) plus capecitabine (C) in HER2+ metastatic breast cancer (MBC): exploratory analyses by prior therapy. European Journal of Cancer Supplements. 7(2). 285–285. 4 indexed citations
8.
Xu, Binghe, et al.. (2009). 5052 An open-label, single arm study of lapatinib and capecitabine in Chinese women with advanced or metastatic breast cancer (MBC). European Journal of Cancer Supplements. 7(2). 276–276. 1 indexed citations
9.
Crown, John, H. A. Burris, Frances M. Boyle, et al.. (2008). Pooled analysis of diarrhea events in patients with cancer treated with lapatinib. Breast Cancer Research and Treatment. 112(2). 317–325. 75 indexed citations
10.
Press, MF, RS Finn, Angelo Di Leo, et al.. (2008). Correlation of HER2 gene amplification, HER2 and EGFR expression (protein and mRNA) with lapatinib efficacy in women with metastatic breast cancer. Journal of Clinical Oncology. 26(15_suppl). 1007–1007. 8 indexed citations
11.
Crown, John, H. A. Burris, Frances M. Boyle, et al.. (2008). Pooled analysis of diarrhea events in patients with cancer treated with lapatinib. Breast Cancer Research and Treatment. 113(2). 409–410. 2 indexed citations
12.
Burris, H.A., Mario E. Lacouture, B. Newstat, et al.. (2007). 2112 POSTER Pooled analysis of skin and diarrhea events in cancer patients treated with lapatinib. European Journal of Cancer Supplements. 5(4). 217–217. 1 indexed citations
13.
Koehler, María, Stephen Chan, B. Newstat, Alex Preston, & Howard A. Burris. (2007). Diarrhea events in cancer patients (pts) treated with lapatinib. Journal of Clinical Oncology. 25(18_suppl). 9125–9125. 3 indexed citations
14.
Geyer, Charles E., Anne Marie Martin, B. Newstat, et al.. (2007). Lapatinib (L) plus capecitabine (C) in HER2+ advanced breast cancer (ABC): Genomic and updated efficacy data. Journal of Clinical Oncology. 25(18_suppl). 1035–1035. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ekaterina Trishkina Breakdown of academic impact, for papers by Lini Pandite Breakdown of academic impact, for papers by Eleonora Restuccia Breakdown of academic impact, for papers by M. Versola Breakdown of academic impact, for papers by S. Stein Breakdown of academic impact, for papers by Karen Afenjar Breakdown of academic impact, for papers by Rubi K. Li Breakdown of academic impact, for papers by Alan J. Koletsky Breakdown of academic impact, for papers by Donggeng Liu Breakdown of academic impact, for papers by Tanja Badovinac Črnjević
Rankless by CCL
2026